01 17GlaxoSmithKline Inc.
01 11340589
02 12216634
03 12289753
04 12398887
05 12452217
06 12577288
07 72606282
08 12787691
09 12967453
10 23003988
01 4DOLUTEGRAVIR SODIUM
02 6DOLUTEGRAVIR SODIUM | ABACAVIR SULFATE | LAMIVUDINE
03 2DOLUTEGRAVIR SODIUM | LAMIVUDINE
04 5DOLUTEGRAVIR SODIUM | RILPIVIRINE HYDROCHLORIDE
01 16TABLET
02 1TABLET FOR SUSPENSION
01 12016-03-28
02 12016-06-08
03 12018-05-14
04 12021-02-26
05 12022-08-09
06 12025-09-02
07 72026-04-28
08 42031-01-24
Patent Expiration Date : 2018-05-14
Date Granted : 2007-01-23
DOLUTEGRAVIR SODIUM, ABACAVIR SULFATE, LAMIVUDINE
Brand Name : TRIUMEQ
Patent Number : 2289753
Filing Date : 1998-05-14
Strength per Unit : 50mg / 600mg / 300mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2018-05-14
Date Granted : 2007-01-23
Patent Expiration Date : 2016-03-28
Date Granted : 2004-07-20
DOLUTEGRAVIR SODIUM, ABACAVIR SULFATE, LAMIVUDINE
Brand Name : TRIUMEQ
Patent Number : 2216634
Filing Date : 1996-03-28
Strength per Unit : 50mg / 600mg / 300mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2016-03-28
Date Granted : 2004-07-20
Patent Expiration Date : 2016-06-08
Date Granted : 1999-06-08
DOLUTEGRAVIR SODIUM, ABACAVIR SULFATE, LAMIVUDINE
Brand Name : TRIUMEQ
Patent Number : 1340589
Filing Date : 1989-06-23
Strength per Unit : 50mg / 600mg / 300mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2016-06-08
Date Granted : 1999-06-08
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
DOLUTEGRAVIR SODIUM, ABACAVIR SULFATE, LAMIVUDINE
Brand Name : TRIUMEQ
Patent Number : 2606282
Filing Date : 2006-04-28
Strength per Unit : 50mg / 600mg / 300mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Brand Name : TIVICAY
Patent Number : 2606282
Filing Date : 2006-04-28
Strength per Unit : 50 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Patent Expiration Date : 2031-01-24
Date Granted : 2018-07-17
DOLUTEGRAVIR SODIUM, ABACAVIR SULFATE, LAMIVUDINE
Brand Name : TRIUMEQ
Patent Number : 2967453
Filing Date : 2011-01-24
Strength per Unit : 50mg / 600mg / 300mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-01-24
Date Granted : 2018-07-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-01-24
Date Granted : 2020-01-07
DOLUTEGRAVIR SODIUM, ABACAVIR SULFATE, LAMIVUDINE
Brand Name : TRIUMEQ
Patent Number : 3003988
Filing Date : 2011-01-24
Strength per Unit : 50mg / 600mg / 300mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-01-24
Date Granted : 2020-01-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Brand Name : TIVICAY
Patent Number : 2606282
Filing Date : 2006-04-28
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Brand Name : TIVICAY
Patent Number : 2606282
Filing Date : 2006-04-28
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-04-28
Date Granted : 2016-04-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
DOLUTEGRAVIR SODIUM, RILPIVIRINE HYDROCHLORIDE
Brand Name : JULUCA
Patent Number : 2398887
Filing Date : 2001-02-26
Strength per Unit : 50 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-02-26
Date Granted : 2008-12-16
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
